Drug intelligence / Profile preview

umbilical cord blood stem cells (Burt Stem Cell Institute)

Development stage
Discontinued
Lead developer
Richard Burt
Modality
Stem Cell Therapies → Cell Therapies
Administration
Intramuscular
01

Overview

Umbilical cord blood stem cells (UCB-SCs) are an investigational allogeneic cell therapy developed by Richard Burt, MD, for the treatment of severe vascular conditions, including critical limb ischemia (CLI), peripheral vascular disease (PVD), and thromboangiitis obliterans (Buerger's disease). The therapy involves the intramuscular injection of a concentrated suspension of total nucleated cells derived from umbilical cord blood into the ischemic limb. These cells are thought to promote therapeutic angiogenesis and vasculogenesis by secreting a variety of pro-angiogenic growth factors and cytokines (paracrine signaling), which stimulate the formation of new blood vessels and improve perfusion in tissues where surgical or endovascular revascularization is not feasible.

Other names
UCB stem cellsCord blood stem cellsUmbilical cord blood-derived stem cells

Beyond the preview

Go deeper on umbilical cord blood stem cells (Burt Stem Cell Institute).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on umbilical cord blood stem cells (Burt Stem Cell Institute).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call